tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NEUP Stock Latest News

Neuphoria initiates strategic review, confirms receipt of indication of interest
The FlyNeuphoria initiates strategic review, confirms receipt of indication of interest
5d ago
NEUP
Neuphoria Therapeutics Declares Dividend Rights Plan
PremiumCompany Announcements
Neuphoria Therapeutics Declares Dividend Rights Plan
20d ago
8K
NEUP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
20d ago
FUSE
NEUP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
23d ago
IBIO
NEUP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
24d ago
IBIO
NEUP
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
26d ago
GM
KO
Why Is Neuphoria Therapeutics Stock (NEUP) Down 65% Today?
Premium
Market News
Why Is Neuphoria Therapeutics Stock (NEUP) Down 65% Today?
26d ago
NEUP
Morning Movers: General Motors and RTX higher following Q3 reports
Premium
The Fly
Morning Movers: General Motors and RTX higher following Q3 reports
26d ago
GE
GM
Neuphoria Therapeutics downgraded to Neutral from Buy at Lucid Capital
PremiumThe Fly
Neuphoria Therapeutics downgraded to Neutral from Buy at Lucid Capital
27d ago
NEUP
Closing Bell Movers: DocGo soars after SteadyMD deal
PremiumThe Fly
Closing Bell Movers: DocGo soars after SteadyMD deal
27d ago
CCK
FLR
Neuphoria Therapeutics Ends SAD Program After Trial Failure
PremiumCompany Announcements
Neuphoria Therapeutics Ends SAD Program After Trial Failure
27d ago
8K
NEUP
Neuphoria Therapeutics Inc trading resumes
PremiumThe Fly
Neuphoria Therapeutics Inc trading resumes
27d ago
NEUP
Neuphoria AFFIRM-1 trial misses primary endpoint, to discontinue SAD program
PremiumThe FlyNeuphoria AFFIRM-1 trial misses primary endpoint, to discontinue SAD program
27d ago
NEUP
Neuphoria Therapeutics Inc trading halted, news pending
Premium
The Fly
Neuphoria Therapeutics Inc trading halted, news pending
27d ago
NEUP
H.C. Wainwright biotech analysts hold an analyst/industry conference call
Premium
The Fly
H.C. Wainwright biotech analysts hold an analyst/industry conference call
1M ago
NEUP
Neuphoria Therapeutics: Strong Cash Position and Promising Pipeline Drive Buy Rating
PremiumRatings
Neuphoria Therapeutics: Strong Cash Position and Promising Pipeline Drive Buy Rating
2M ago
NEUP
Neuphoria Therapeutics price target raised to $35 from $18 at Maxim
PremiumThe Fly
Neuphoria Therapeutics price target raised to $35 from $18 at Maxim
2M ago
NEUP
Neuphoria Therapeutics completes target enrollment in Phase 3 AFFIRM-1 trial
PremiumThe Fly
Neuphoria Therapeutics completes target enrollment in Phase 3 AFFIRM-1 trial
2M ago
NEUP
Neuphoria Therapeutics initiated with a Buy at Lucid Capital
PremiumThe Fly
Neuphoria Therapeutics initiated with a Buy at Lucid Capital
2M ago
NEUP
Neuphoria Therapeutics’s BNC210: Buy Rating Affirmed Ahead of Pivotal Phase 3 AFFIRM-1 Trial
PremiumRatingsNeuphoria Therapeutics’s BNC210: Buy Rating Affirmed Ahead of Pivotal Phase 3 AFFIRM-1 Trial
3M ago
NEUP
Neuphoria Therapeutics Delays 10-Q Filing
Premium
Company Announcements
Neuphoria Therapeutics Delays 10-Q Filing
6M ago
NEUP
Neuphoria Therapeutics provides review of 2024, highlights 2025 plans
Premium
The Fly
Neuphoria Therapeutics provides review of 2024, highlights 2025 plans
7M ago
NEUP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >